JILIN ZHONGKE BIO-ENGINEERING

jilin-zhongke-bio-engineering-logo

Jilin Zhongke Bio-Engineering engages in stem cell collection, stem cell preparation of production, transplantation, and other services.

#SimilarOrganizations #Financial #More

JILIN ZHONGKE BIO-ENGINEERING

Industry:
Biotechnology Health Care Medical

Founded:
2007-05-14

Status:
Active

Contact:
86(431)85810980

Email Addresses:
[email protected]

Total Funding:
19 M CNY

Technology used in webpage:
ASP.NET IIS IIS 8 DynaDot


Similar Organizations

henry-ford-health-system-logo

Henry Ford Health System

Henry Ford Health System (HFHS) is one of the nationโ€™s leading comprehensive, integrated health systems.

illumina-logo

Illumina

Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.

Stock Details


Company's stock symbol is NEEQ:833207

Investors List

chengpu-touzi_image

Chengpu Touzi

Chengpu Touzi investment in Series B - Jilin Zhongke Bio-Engineering

chengpu-touzi_image

Chengpu Touzi

Chengpu Touzi investment in Series A - Jilin Zhongke Bio-Engineering

shanghai-xinhu-venture-capital_image

Shanghai Xinhu Venture Capital

Shanghai Xinhu Venture Capital investment in Series A - Jilin Zhongke Bio-Engineering

guangzhou-shengyuan-technology_image

Guangzhou Shengyuan Technology

Guangzhou Shengyuan Technology investment in Angel Round - Jilin Zhongke Bio-Engineering

Investments List

Date Company Article Money raised
2021-06-22 AIForceTech Jilin Zhongke Bio-Engineering investment in Series A - AIForceTech 1.6 M USD

More informations about "Jilin Zhongke Bio-Engineering"

Jilin Zhongke Bio-Engineering - Crunchbase

Jilin Zhongke Bio-Engineering engages in stem cell collection, stem cell preparation of production, transplantation, and other services. Changchun, Jilin, China; 11-50; ... 750 Number of โ€ฆSee details»

Jilin Zhongke Bio-Engineering - Funding, Financials ... - Crunchbase

Jilin Zhongke Bio-Engineering engages in stem cell collection, stem cell preparation of production, transplantation, and other services.See details»

Jilin Zhongke Bio-engineering Joint Stock Co., Ltd.

Explore Jilin Zhongke Bio-engineering Joint Stock Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 3 literature. Biomedical products. Data. Feature. Plans. Sign Up for โ€ฆSee details»

Jilin Zhongke Bio-Engineering | Investor | RadialReport

Jilin Zhongke Bio-Engineering engages in stem cell collection, stem cell preparation of production, transplantation, and other services. Technology: Regenerative Medicine Industry: โ€ฆSee details»

Meridigen Biotech Company Profile | Management and Employees โ€ฆ

Meridigen is a drug discovery and translational research and development organization primarily focused on the discovery and development of molecular targeted therapies using stem cell โ€ฆSee details»

Jilin Zhongke Bio-Engineering - Crunchbase

Jilin Zhongke Bio-Engineering engages in stem cell collection, stem cell preparation of production, transplantation, and other services.See details»

Jilin Zhongke Bio-Engineering - Zefyron Investor

Jilin Zhongke Bio-Engineering engages in stem cell collection, stem cell preparation of production, transplantation, and other servicesSee details»

Zhongke Nuo Saihaoyuan (Jilin) Bioengineering Co., Ltd.

Jul 6, 2023 Explore Zhongke Nuo Saihaoyuan (Jilin) Bioengineering Co., Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»

Jilin Zhongke Bio-engineering Stock Co Ltd - Bloomberg.com

Company profile page for Jilin Zhongke Bio-engineering Stock Co Ltd including stock price, company news, executives, board members, and contact informationSee details»

Meridigen Biotech - Overview, News & Similar companies

Meridigen has formed alliance with Jilin Zhongke Bio-engineering Co., LTD. And Jilin University in China. ... Meridigen is a drug discovery and translational research and development โ€ฆSee details»

Jilin Zhongke Bio-engineering Joint Stock Co., Ltd. signed the โ€ฆ

Aug 24, 2021 Jilin Zhongke Bio-engineering Joint Stock Co., Ltd. signed the share transfer agreement to acquire a 51% stake in Zhongzhu Zhongke Stem Cell Gene Technology Co., โ€ฆSee details»

Jilin Zhongke Bio-Engineering - Investments, Portfolio

Jilin Zhongke Bio-Engineering engages in stem cell collection, stem cell preparation of production, transplantation, and other services.See details»

Jilin Zhongke Bio-Engineering โ€” 1 Investments, Portfolio, Team โ€ฆ

Jilin Zhongke Bio-Engineering. Search. Overview Investments Unlock datapoints. Portfolio analytics Team News & Media. Add fund to favorites. Save this fund for later to form your own โ€ฆSee details»

Shi Wen Feng: Positions, Relations and Network - MarketScreener

Jilin Zhongke Bio-engineering Joint Stock Co., Ltd. engages in medical research and experimental development. It offers stem cell technology research and development as well as immune cell โ€ฆSee details»

Zhong Min Xu: Positions, Relations and Network - MarketScreener

Jun 23, 2014 Director/Board Member at Jilin Zhongke Bio-engineering Joint Stock Co., Ltd., Discover Zhong Min Xu's known position history, network and 11 relationships. Find out about โ€ฆSee details»

Trading on hope - Nature Biotechnology

The cells are supplied by Jilin Zhongke Bio-Engineering, which claims to produce a variety of fetal and adult stem cells for treating numerous conditions and for cosmetic enhancement.See details»

Jilin Zhongke Bio-Engineering - Tech Stack, Apps, Patents

Jilin Zhongke Bio-Engineering engages in stem cell collection, stem cell preparation of production, transplantation, and other services.See details»

Correction to: Identification of appropriate reference genes for โ€ฆ

Oct 8, 2021 Jilin Zhongke Bio-Engineering Co., Ltd, Building 2, 3355 Guigu Street, Changchun, 130012, Jilin, China. Yimin Wang. Authors. Xiuying Li. View author publications. You can also โ€ฆSee details»

Comprehensive characterization of four different populations of โ€ฆ

4 Jilin Zhongke Bio-engineering, Co., Ltd., Changchun, Jilin 130012, P.R. China. PMID: 24970492 PMCID: PMC4121354 DOI: 10.3892/ijmm.2014.1821 Abstract In the present study, we โ€ฆSee details»

Innovations and development of Covid-19 vaccines: A patent review

Jan 1, 2022 The rapid designing, development, and success of mRNA-based COVID-19 vaccines need to be credited to different organizations including academic labs, small biotech โ€ฆSee details»

linkstock.net © 2022. All rights reserved